Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: A meta-analysis and systematic review

Song Zhang; Panpan Hao; Jiaxin Li; Qi Zhang; Xiaoying Yin; Jiali Wang; Yuguo Chen

doi:10.3389/fcvm.2023.1054187

Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: A meta-analysis and systematic review

Front Cardiovasc Med. 2023 Feb 10:10:1054187. doi: 10.3389/fcvm.2023.1054187. eCollection 2023.

Authors

Song Zhang^{1

2

3

4}, Panpan Hao^{3

4}, Jiaxin Li^{1

2

3

4}, Qi Zhang^{1

2

3

4}, Xiaoying Yin^{1

2

3

4}, Jiali Wang^{1

2

3

4}, Yuguo Chen^{1

2

3

4}

Affiliations

¹ Department of Emergency and Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China.
² Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine of Shandong Province, Institute of Emergency and Critical Care Medicine of Shandong University, Qilu Hospital of Shandong University, Jinan, China.
³ The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, Jinan, China.
⁴ The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Qilu Hospital of Shandong University, Jinan, China.

Abstract

Background and aims: The predictive value of growth differentiation factor-15 (GDF-15) for individual cardiovascular outcomes remained controversial in patients with coronary artery disease (CAD). We aimed to investigate the effects of GDF-15 on all-cause death, cardiovascular death, MI and stroke in CAD patients.

Methods: We searched PubMed, EMBASE, Cochrane library and Web of Science till 30 December, 2020. Hazard ratios (HRs) were combined with fixed or random effect meta-analyses. Subgroup analyses were performed in different disease types. Sensitivity analyses were used to evaluate the stability of the results. Publication bias was tested using funnel plots.

Results: A total of 10 studies with 49,443 patients were included in this meta-analysis. Patients with the highest GDF-15 concentrations had significantly increased risk of all-cause death (HR 2.24; 95% CI: 1.95-2.57), cardiovascular death (HR 2.00; 95% CI: 1.66-2.42), MI (HR 1.42; 95% CI: 1.21-1.66) after adjusting clinical characteristics and prognostic biomarkers (hs-TnT, cystatin C, hs-CRP, and NT-proBNP) but except for stroke (HR 1.43; 95% CI: 1.01-2.03, p = 0.05). For the outcome of all-cause death and cardiovascular death, subgroup analyses revealed consistent results. Sensitivity analyses showed that the results were stable. Funnel plots showed that there was no publication bias.

Conclusion: In CAD patients with elevated GDF-15 levels on admission, there were independently significant risks for all-cause death and cardiovascular death. The highest concentrations of GDF-15 had a lower predictive effect on MI than all-cause death and cardiovascular death. The association of GDF-15 with the outcome of stroke needs to be further studied.

Keywords: coronary artery disease; growth differentiation factor-15; independent prognostic value; myocardial infarction; systematic review and meta-analysis.

Publication types

Systematic Review